New balloon could offer alternative for clogged arteries
NCT ID NCT06822712
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study compares a new balloon coated with sirolimus to an existing balloon coated with paclitaxel for treating blocked heart arteries. About 250 adults with coronary artery disease will be randomly assigned to receive one of the two balloons during a procedure to open their arteries. The main goal is to see if the sirolimus balloon works as well as the paclitaxel balloon in keeping arteries open after 9 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
sirolimus-coated balloon catheter
What this could lead to
If it works, this could offer a new treatment option for blocked heart arteries that may be as effective as current options.
What could go wrong
This is a noninferiority trial, meaning it aims to show the new balloon is not worse than the existing one, not that it is better. The study is still recruiting and results are not yet available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERIAL DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Hospital of Lanzhou University
RECRUITINGLanzhou, Gansu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••